INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 75 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 75 | -99.3% | 0.00% | -100.0% |
| Q3 2017 | $15,000 | -40.0% | 10,120 | +11.0% | 0.00% | 0.0% |
| Q2 2017 | $25,000 | -24.2% | 9,120 | +12.3% | 0.00% | 0.0% |
| Q1 2017 | $33,000 | -2.9% | 8,120 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $34,000 | +277.8% | 8,120 | +515.2% | 0.00% | – |
| Q3 2016 | $9,000 | +12.5% | 1,320 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | -55.6% | 1,320 | -47.1% | 0.00% | -100.0% |
| Q4 2015 | $18,000 | – | 2,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|